AKAP3 overexpression significantly enhanced malignant behavior in four BC cell lines, which was robustly reversed by AKAP3 knockdown via activation of the PTEN/PI3K/AKT/mTOR signaling. This evidence concerns the gene AKT1 and breast cancer.